CD40LG and progressive multifocal leukoencephalopathy: In addition to providing a logical mechanism linking intrathecal synthesis of lipid-reactive IgM with protection from natalizumab-associated PML [11], our data also provide new insight into why this antibody response is also associated with a more aggressive MS disease course [38].